We now are showing the industry that we care about the health of our children," sponsor Rep. Barbara Drummond said.

Key Takeaways Eli Lilly will acquire Verve for roughly $1 billionVerve is developing a one-time gene-editing treatment for ...

Zydus clarified that the observations received were minor and unrelated to data integrity. Shares of Zydus Lifesciences Ltd ended at ₹957.80, down by ₹1.10, or 0.11%, on the BSE.

In the grocery aisle, you'll find everything from cow, sheep, and goat milk yogurts, to whole, low fat, lactose-free, soy, ...

Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing ...

Packaged-food maker General Mills Inc. is joining Kraft Heinz Co. in removing synthetic food dyes from its products in the United States by the end of 2027--a move that will eliminate ingredients such ...

Global Phase 3 BRAVE study will evaluate the efficacy and safety of omaveloxolone in children 2 to <16 years old with ...